InnoGene BioTech

Shanghai, China · Founded 2022 · Privately Held (backing)

Developer of green synthetic biological products. InnoGene BioTech is based in Shanghai, China and was founded in 2022. Its last reported valuation was $27 million in Dec 2022. It has raised $41.5 million.

Last reported valuation

$27.0M

Oct 2026

Priced at

—

Total raised

$41.5M

Last round

—

How much has InnoGene BioTech raised?

$41.5Macross 0 recorded rounds

Free account

More of InnoGene BioTech with a free account

·Watch InnoGene BioTech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

InnoGene BioTech investors

9 investors are on record for InnoGene BioTech, including Hefei Industry Investment Group, Furong Capital, Flyfot Ventures and Fontus Capital.

For fundraisers

Raising for a company like InnoGene BioTech?

9 investors have backed InnoGene BioTech.

See all 9 investors →

Frequently asked about InnoGene BioTech

How much has InnoGene BioTech raised?: InnoGene BioTech has raised $41.5M in total across 0 recorded funding rounds.